IL326919A - Cell preparations derived from dedifferentiated and reprogrammed cells - Google Patents

Cell preparations derived from dedifferentiated and reprogrammed cells

Info

Publication number
IL326919A
IL326919A IL326919A IL32691926A IL326919A IL 326919 A IL326919 A IL 326919A IL 326919 A IL326919 A IL 326919A IL 32691926 A IL32691926 A IL 32691926A IL 326919 A IL326919 A IL 326919A
Authority
IL
Israel
Prior art keywords
cell compositions
reprogrammed cells
compositions derived
dedifferentiated reprogrammed
dedifferentiated
Prior art date
Application number
IL326919A
Other languages
English (en)
Hebrew (he)
Original Assignee
Viacyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/761,078 external-priority patent/US9109245B2/en
Application filed by Viacyte Inc filed Critical Viacyte Inc
Publication of IL326919A publication Critical patent/IL326919A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012Cell encapsulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/72Transferases [EC 2.]
    • C12N2501/727Kinases (EC 2.7.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL326919A 2013-02-06 2014-02-06 Cell preparations derived from dedifferentiated and reprogrammed cells IL326919A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/761,078 US9109245B2 (en) 2009-04-22 2013-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
PCT/US2014/015156 WO2014124172A1 (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells

Publications (1)

Publication Number Publication Date
IL326919A true IL326919A (en) 2026-05-01

Family

ID=50239931

Family Applications (6)

Application Number Title Priority Date Filing Date
IL326919A IL326919A (en) 2013-02-06 2014-02-06 Cell preparations derived from dedifferentiated and reprogrammed cells
IL321825A IL321825A (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
IL290717A IL290717B2 (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
IL311689A IL311689B2 (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
IL239953A IL239953B (en) 2013-02-06 2015-07-15 Cell assemblies derived from reprogrammed undifferentiated cells
IL283088A IL283088B (en) 2013-02-06 2021-05-10 Cell compositions derived from dedifferentiated reprogrammed cells

Family Applications After (5)

Application Number Title Priority Date Filing Date
IL321825A IL321825A (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
IL290717A IL290717B2 (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
IL311689A IL311689B2 (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
IL239953A IL239953B (en) 2013-02-06 2015-07-15 Cell assemblies derived from reprogrammed undifferentiated cells
IL283088A IL283088B (en) 2013-02-06 2021-05-10 Cell compositions derived from dedifferentiated reprogrammed cells

Country Status (8)

Country Link
EP (1) EP2954045A1 (enExample)
JP (5) JP6517702B2 (enExample)
AU (5) AU2014214879A1 (enExample)
CA (2) CA3212301A1 (enExample)
HK (1) HK1218139A1 (enExample)
IL (6) IL326919A (enExample)
RU (2) RU2675928C2 (enExample)
WO (1) WO2014124172A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
SG11201700874SA (en) 2014-08-04 2017-03-30 Takeda Pharmaceuticals Co Method for proliferation of pancreatic progenitor cells
JP6705911B2 (ja) * 2016-04-14 2020-06-03 ヤンセン バイオテツク,インコーポレーテツド 多能性幹細胞の中腸内胚葉細胞への分化
ES2973213T3 (es) * 2016-05-18 2024-06-19 Univ Keio Medio de cultivo celular para cultivo de organoide, método de cultivo y organoide
US11746331B2 (en) 2017-01-27 2023-09-05 Kaneka Corporation Endodermal cell population, and method for producing cell population of any of three germ layers from pluripotent cell
EP3638205A4 (en) 2017-06-14 2021-03-17 Semma Therapeutics, Inc. DEVICES AND METHODS FOR ADMINISTERING THERAPEUTICS
JP2020527956A (ja) * 2017-07-21 2020-09-17 センマ・セラピューティクス・インコーポレーテッド 幹細胞由来の膵臓ベータ細胞の再凝集
US20210292708A1 (en) * 2018-08-03 2021-09-23 Kyoto University Cell production method
TWI862513B (zh) * 2018-09-19 2024-11-21 日商千紙鶴治療公司 包含胰島素產生細胞之細胞集團、包含該細胞集團之醫藥、其用途及製造方法
JP7555975B2 (ja) 2019-05-31 2024-09-25 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド 生体適合性メンブレン複合体
WO2020243666A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
JP2022534545A (ja) 2019-05-31 2022-08-01 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド 生体適合性メンブレン複合体
CA3257300A1 (en) 2019-05-31 2025-06-12 W. L. Gore & Associates, Inc. Cell encapsulation devices with controlled oxygen diffusion distances
EP4647080A3 (en) 2020-07-31 2026-02-18 Vertex Pharmaceuticals Incorporated Differentiation of pancreatic endocrine cells
US20260097083A1 (en) * 2022-09-26 2026-04-09 Kyoto University Method for producing pancreatic endoderm cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1165113E (pt) * 1999-04-06 2008-09-23 Genentech Inc Utilização de ligandos de receptor erbb no tratamento da diabetes
US6759039B2 (en) * 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
CA2435826A1 (en) * 2001-01-24 2002-08-01 The Government Of The United States Of America Differentiation of stem cells to pancreatic endocrine cells
EP1941032A2 (en) * 2005-10-14 2008-07-09 Regents Of The University Of Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
WO2007143193A1 (en) * 2006-06-02 2007-12-13 University Of Georgia Research Foundation, Inc. Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems
JP2012508584A (ja) * 2008-11-14 2012-04-12 ヴィアサイト,インコーポレイテッド ヒト多能性幹細胞由来膵臓細胞のカプセル化
ES2849181T3 (es) * 2009-04-22 2021-08-16 Viacyte Inc Composiciones celulares derivadas de células reprogramadas desdiferenciadas
US9109245B2 (en) * 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
CN107603943B (zh) * 2009-04-27 2019-10-11 威盛细胞有限公司 支持多能细胞生长的小分子和其方法
EP2436397B1 (en) * 2009-05-29 2017-05-10 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition containing antagonist of egf family ligand as component

Also Published As

Publication number Publication date
RU2018144412A (ru) 2019-03-25
JP7550830B2 (ja) 2024-09-13
HK1218139A1 (zh) 2017-02-03
RU2675928C2 (ru) 2018-12-25
JP2016506736A (ja) 2016-03-07
IL239953B (en) 2021-05-31
CA2898431C (en) 2023-10-17
JP6517702B2 (ja) 2019-05-22
AU2014214879A1 (en) 2015-07-30
IL290717B2 (en) 2024-10-01
RU2754089C2 (ru) 2021-08-26
IL311689A (en) 2024-05-01
AU2022200075A1 (en) 2022-02-03
AU2019201314B2 (en) 2021-10-14
RU2015131279A (ru) 2017-03-13
RU2018144412A3 (enExample) 2020-02-14
AU2019201314A1 (en) 2019-03-14
CA2898431A1 (en) 2014-08-14
JP2019146578A (ja) 2019-09-05
WO2014124172A1 (en) 2014-08-14
AU2026201562A1 (en) 2026-03-19
AU2023202507A1 (en) 2023-05-11
EP2954045A1 (en) 2015-12-16
IL283088A (en) 2021-06-30
JP6721752B2 (ja) 2020-07-15
CA3212301A1 (en) 2014-08-14
IL239953A0 (en) 2015-08-31
JP2020178694A (ja) 2020-11-05
JP2025000625A (ja) 2025-01-07
IL311689B1 (en) 2025-08-01
AU2023202507B2 (en) 2025-12-04
IL283088B (en) 2022-04-01
IL321825A (en) 2025-08-01
IL290717A (en) 2022-04-01
JP7250731B2 (ja) 2023-04-03
IL311689B2 (en) 2025-12-01
JP2023017838A (ja) 2023-02-07
AU2022200075C1 (en) 2023-07-06
IL290717B1 (en) 2024-06-01
AU2022200075B2 (en) 2023-02-02

Similar Documents

Publication Publication Date Title
IL290717A (en) Cell preparations derived from dedifferentiated and reprogrammed cells
ZA201509111B (en) Compositions for introducing rna into cells
PL2982002T3 (pl) Niewodne kompozycje elektrolitów
IL245572A0 (en) cell
EP3027789A4 (en) Modular electrochemical cells
PL3050142T3 (pl) Ogniwo elektrochemiczne umożliwiające wielokrotne ładowanie
SG11201509558VA (en) Back-contact-type solar cell
EP2961825A4 (en) STRUCTURE FOR CULTIVATION OF CELLS
PL3062382T3 (pl) Zespół ogniw akumulatorowych
PL2951877T3 (pl) Kompozycja elektrolitu do ogniw elektrochemicznych
PL3029765T3 (pl) Zespół ogniw akumulatorowych
EP3018750A4 (en) Cell
GB201310031D0 (en) Cell
GB201306326D0 (en) Fuel cells
PL2965371T3 (pl) Kompozycja oliwinowa o ulepszonej wydajności ogniwa
EP3038195A4 (en) LITHIUM CELL
GB201307880D0 (en) Fuel cells
SG11201507653YA (en) Composition for anode in fuel cell
GB201317614D0 (en) Fuel cell
GB201312803D0 (en) Cell component
GB201218280D0 (en) Photovoltaic cell
GB201304302D0 (en) Electrochemical cells
GB201301952D0 (en) Electrochemical cells
GB201518180D0 (en) Fuel cell
EP3038196A4 (en) Solid electrolyte fuel cell